Shenzhen New Industries Biomedical Engineering Co., Ltd.

XSEC:300832 Stock Report

Market Cap: CN¥52.2b

Shenzhen New Industries Biomedical Engineering Management

Management criteria checks 3/4

Shenzhen New Industries Biomedical Engineering's CEO is Wei Rao, appointed in Aug 2012, has a tenure of 12.42 years. directly owns 13.77% of the company’s shares, worth CN¥7.18B. The average tenure of the management team and the board of directors is 12.4 years and 3 years respectively.

Key information

Wei Rao

Chief executive officer

CN¥4.6m

Total compensation

CEO salary percentagen/a
CEO tenure12.4yrs
CEO ownership13.8%
Management average tenure12.4yrs
Board average tenure3yrs

Recent management updates

Recent updates

CEO

Wei Rao (60 yo)

12.4yrs

Tenure

CN¥4,592,000

Compensation

Dr. Wei Rao has been Chairman of the Board and General Manager at Shenzhen New Industries Biomedical Engineering Co., Ltd since August 2012 and serves as its Director. Dr. Rao joined Shenzhen New Industrie...

Leadership Team

NamePositionTenureCompensationOwnership
Wei Rao
Chairman of the Board & GM12.4yrsCN¥4.59m13.77%
CN¥ 7.2b
Chenliu Ding
CFO & Deputy GM12.4yrsCN¥2.76m0.093%
CN¥ 48.6m
Lei Zhang
Secretary of the Board & Deputy GM9.3yrsCN¥2.76m0.43%
CN¥ 221.8m

12.4yrs

Average Tenure

49yo

Average Age

Experienced Management: 300832's management team is seasoned and experienced (12.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Wei Rao
Chairman of the Board & GM12.4yrsCN¥4.59m13.77%
CN¥ 7.2b
Dengke Liu
Chairman of the Supervisory Board9.3yrsno datano data
Heming Weng
Non-Independent Director3.3yrsno datano data
Jie Ma
Non-Employee Supervisor3.3yrsno data0.000010%
CN¥ 5.2k
He Xin
Employee Representative Supervisor3.3yrsno datano data
Qianhui Wu
Independent Director2.7yrsno datano data
Jie Rao
Non-Independent Directorless than a yearno data3.11%
CN¥ 1.6b
Min Zhang
Independent Directorless than a yearno datano data
Xu Li
Non-Independent Directorless than a yearno datano data
Yi Zhi
Independent Directorless than a yearno datano data

3.0yrs

Average Tenure

35yo

Average Age

Experienced Board: 300832's board of directors are considered experienced (3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 12:25
End of Day Share Price 2025/01/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shenzhen New Industries Biomedical Engineering Co., Ltd. is covered by 20 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pei ChengChina Galaxy Securities Co., Ltd.
Jin ZhangChina International Capital Corporation Limited
Zhu ChenCitic Securities Co., Ltd.